EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies

Qun He, Da Hu, Fuqiang Zheng, Wenxuan Chen, Kanghong Hu iD, Jinbiao Liu, Chenguang Yao, Hanluo Li, Yanhong Wei

Viruses · 2024

DOI: 10.3390/v16020213 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Qun He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering …. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuhan Knowledge Innovation Special Basic Research Project, the Open Funding of the Key Laboratory of Fermentation Engineering (Ministry of Education), the Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID-19) global pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has been marked by severe cases demonstrating a “cytokine storm”, an upsurge of pro-inflammatory cytokines in the bloodstream. NLRP3 inflammasomes, integral to the innate immune system, are speculated to be activated by SARS-CoV-2 within host cells. This review investigates the potential correlation between NLRP3 inflammasomes and COVID-19, exploring the cellular and molecular mechanisms through which SARS-CoV-2 triggers their activation. Furthermore, promising strategies targeting NLRP3 inflammasomes are proposed to mitigate the excessive inflammatory response provoked by SARS-CoV-2 infection. By synthesizing existing studies, this paper offers insights into NLRP3 as a therapeutic target, elucidating the interplay between COVID-19 and its pathophysiology. It serves as a valuable reference for future clinical approaches in addressing COVID-19 by targeting NLRP3, thus providing potential avenues for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansCytokinesInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinSARS-CoV-2

Stichwörter der Autor:innen

COVID-19NLRP3 inflammasomeSARS-CoV-2cytokine stormtherapeutic targets

Substanzen

CytokinesInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, human

Autor:innen und Institutionen

  • Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068,…
  • Sinopharm Animal Health Corporation Ltd., Wuhan 430075, China.

ORCID-Profile: Kanghong Hu

Förderung

  • Wuhan Knowledge Innovation Special Basic Research Project
  • the Open Funding of the Key Laboratory of Fermentation Engineering (Ministry of Education)
  • the Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), China

Zitieren

APA

He, Q., Hu, D., Zheng, F., Chen, W., Hu, K., Liu, J., Yao, C., Li, H., & Wei, Y. (2024). Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies. Viruses. https://doi.org/10.3390/v16020213

Vancouver

He Q, Hu D, Zheng F, Chen W, Hu K, Liu J, et al. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies. Viruses. 2024. doi:10.3390/v16020213

BibTeX
@article{He2024,
  author = {He, Qun and Hu, Da and Zheng, Fuqiang and Chen, Wenxuan and Hu, Kanghong and Liu, Jinbiao and Yao, Chenguang and Li, Hanluo and Wei, Yanhong},
  title = {Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16020213}
}
Kostenlos starten →